LPGO — Lipigon Pharmaceuticals AB Share News
0.000.00%
Last trade - 00:00- SEK1.64m
- -SEK8.58m
Brief: Lipigon Receives CTA Approval For Lipid-Lowering Candidate Lipisense
Brief: Lipigon and HitGen Announce Achievement Of Important Milestone In Dyslipidemia Project
Brief: Lipigon Says Prioritized Patent Application In US Confirmed
Brief: Lipigon And HitGen Extend Collaboration Agreement On Dyslipidemia Project
Brief: Lipigon Announces Positive Results From Preclinical Study For Lipid-Lowering Drug Candidate Lipisense
Brief: Lipigon Q3 Operating Loss Widens To SEK 11.5 Mln
Brief: Lipigon And 5Prime Sciences To Optimize Coming Clinical Trials
Brief: Lipigon Announces Positive Results From Preparatory Preclinical Safety Study For Lipid-Lowering Drug Candidate Lipisense
Brief: Lipigon Pharmaceuticals Q2 Operating Loss Widens To SEK 10.4 Mln
Brief: Lipigon Pharmaceuticals Q1 Operating Loss Widens To SEK 4.9 Mln
Brief: Lipigon Pharmaceuticals AB Says Expanded Agreement With HitGen